{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:00:50Z","timestamp":1793638850246,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This review is to systematically explore the relationship between muscle dysfunction and diabetes in adults, and to examine the impact of glycemic variability on muscle health and the development of diabetes-related complications. The review was conducted using three databases: MEDLINE, Scopus, and EMBASE, targeting peer-reviewed journal articles written in English and published from January 2014 to September 2024. The methodological quality assessment of the eligible studies was conducted using Joanna Briggs Institute Critical Appraisal Checklists. A total of 17 studies were included. Most studies were undertaken in Asian countries (<jats:italic>n<\/jats:italic>\u2009=\u200911) and focused on adults with type 2 diabetes (<jats:italic>n<\/jats:italic>\u2009=\u200912). There were 8,392 adults with diabetes, and their mean age ranged from 52 to 75\u00a0years old. The measurements for muscle function and glycemic variability varied across studies. The research findings regarding the relationship between muscle dysfunction and glycemic variability metrics among adults with diabetes, both with and without complications were inconsistent. For adults with diabetes and sarcopenic obesity, poor glycemic control was identified as an independent risk factor for sarcopenic obesity. Additionally, all included studies were rated as moderate or high quality in relation to their methodology. In conclusion, this review underscores the complex and inconsistent relationship between glycemic variability and muscle dysfunction in older adults with diabetes. Poor glycemic management is a significant risk factor for sarcopenic obesity, highlighting the need for tailored interventions to improve glycemic control and muscle health in this population.<\/jats:p>","DOI":"10.1007\/s11154-025-09942-z","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T11:29:39Z","timestamp":1738150179000},"page":"837-855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the relationship between glycemic variability and muscle dysfunction in adults with diabetes: A systematic review"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1447-7152","authenticated-orcid":false,"given":"Shanshan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof","family":"Andrikopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-6735","authenticated-orcid":false,"given":"Yan-Chuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-9447","authenticated-orcid":false,"given":"David","family":"Sibbritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-2466","authenticated-orcid":false,"given":"Wenbo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"9942_CR1","unstructured":"Centers for Disease Control and Prevention. National diabetes statistics report. 2024a. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 22 July 2024."},{"key":"9942_CR2","unstructured":"International Diabetes Federation. Diabetes in South-East Asia 2021. 2021. https:\/\/diabetesatlas.org\/idfawp\/resource-files\/2021\/11\/IDF-Atlas-Factsheet-2021_SEA.pdf. Accessed 22 July 2024."},{"key":"9942_CR3","unstructured":"Australian Institute of Health and Welfare. Diabetes: Australian facts. 2024. https:\/\/www.aihw.gov.au\/reports\/diabetes\/diabetes\/contents\/diabetes-risk-factors\/impaired-fasting-glucose. Accessed 22 July 2024."},{"key":"9942_CR4","unstructured":"World Health Organization. Obesity and overweight. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 22 July 2024."},{"key":"9942_CR5","unstructured":"Centers for Disease Control and Prevention. Obesity and Severe Obesity Prevalence in adults: United States, August 2021-August 2023. 2024b. https:\/\/stacks.cdc.gov\/view\/cdc\/159281. Accessed 22 July 2024."},{"key":"9942_CR6","doi-asserted-by":"crossref","unstructured":"Australian Institute of Health and Welfare. Overweight and obesity. 2024. https:\/\/www.aihw.gov.au\/reports\/overweight-obesity\/overweight-and-obesity\/contents\/overweight-and-obesity. Accessed 22 July 2024.","DOI":"10.1093\/hesc\/9780198866671.003.0021"},{"issue":"3","key":"9942_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.glohj.2024.08.006","volume":"8","author":"ES Tee","year":"2024","unstructured":"Tee ES, Voon SH. Combating obesity in Southeast Asia countries: current status and the way forward. Global Health Journal. 2024;8(3):147\u201351. https:\/\/doi.org\/10.1016\/j.glohj.2024.08.006.","journal-title":"Global Health Journal"},{"key":"9942_CR8","unstructured":"Disease Prevention and Control Bureau of the National Health Commission. Report on nutrition and chronic disease status of Chinese residents. 2020. Beijing: People\u2019s Health Publishing House; 2022."},{"issue":"5","key":"9942_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2337\/dc17-1962","volume":"41","author":"C Bommer","year":"2018","unstructured":"Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, B\u00e4rnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963\u201370. https:\/\/doi.org\/10.2337\/dc17-1962.","journal-title":"Diabetes Care"},{"issue":"1","key":"9942_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","volume":"47","author":"ED Parker","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic costs of diabetes in the US in 2022. Diabetes Care. 2024;47(1):26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085.","journal-title":"Diabetes Care"},{"issue":"11","key":"9942_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1377\/hlthaff.2015.0633","volume":"34","author":"YC Wang","year":"2015","unstructured":"Wang YC, Pamplin J, Long MW, Ward ZJ, Gortmaker SL, Andreyeva T. Severe obesity in adults cost state Medicaid programs nearly $8 billion in 2013. Health Aff. 2015;34(11):1923\u201331. https:\/\/doi.org\/10.1377\/hlthaff.2015.0633.","journal-title":"Health Aff"},{"issue":"19","key":"9942_CR12","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.3390\/ijerph191912611","volume":"19","author":"MD Butt","year":"2022","unstructured":"Butt MD, Ong SC, Wahab MU, Rasool MF, Saleem F, Hashmi A, et al. Cost of illness analysis of type 2 diabetes mellitus: the findings from a lower-middle income country. Int J Environ Res Public Health. 2022;19(19):12611. https:\/\/doi.org\/10.3390\/ijerph191912611.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"9942_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/1753-0407.12913","volume":"11","author":"A Misra","year":"2019","unstructured":"Misra A, Gopalan H, Jayawardena R, Hills AP, Soares M, Reza-Albarr\u00e1n AA, et al. Diabetes in developing countries. J Diabetes. 2019;11(7):522\u201339. https:\/\/doi.org\/10.1111\/1753-0407.12913.","journal-title":"J Diabetes"},{"key":"9942_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00592-016-0880-y","volume":"53","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient\u2019s mobility and independence. Acta Diabetol. 2016;53:879\u201389. https:\/\/doi.org\/10.1007\/s00592-016-0880-y.","journal-title":"Acta Diabetol"},{"issue":"6","key":"9942_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0b013e328358d59b","volume":"24","author":"JD Walston","year":"2012","unstructured":"Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012;24(6):623\u20137. https:\/\/doi.org\/10.1097\/BOR.0b013e328358d59b.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"9942_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13098-021-00707-7","volume":"13","author":"Y Ai","year":"2021","unstructured":"Ai Y, Xu R, Liu L. The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):93. https:\/\/doi.org\/10.1186\/s13098-021-00707-7.","journal-title":"Diabetol Metab Syndr"},{"key":"9942_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fendo.2020.00332","volume":"11","author":"E Roh","year":"2020","unstructured":"Roh E, Choi KM. Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol. 2020;11:332. https:\/\/doi.org\/10.3389\/fendo.2020.00332.","journal-title":"Front Endocrinol"},{"key":"9942_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clnesp.2023.09.920","volume":"58","author":"YY Zhou","year":"2023","unstructured":"Zhou YY, Wang JF, Yao Q, Jian QF, Luo ZP. Prevalence of sarcopenic obesity in patients with diabetes and adverse outcomes: a systematic review and meta-analysis. Clin Nutr ESPEN. 2023;58:128\u201335. https:\/\/doi.org\/10.1016\/j.clnesp.2023.09.920.","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"9942_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/ds20-0013","volume":"33","author":"AJ Sinclair","year":"2020","unstructured":"Sinclair AJ, Abdelhafiz AH. Challenges and strategies for diabetes management in community-living older adults. Diabetes Spectr. 2020;33(3):217\u201327. https:\/\/doi.org\/10.2337\/ds20-0013.","journal-title":"Diabetes Spectr"},{"issue":"9","key":"9942_CR20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","volume":"31","author":"AJ Sinclair","year":"2017","unstructured":"Sinclair AJ, Abdelhafiz AH, Rodr\u00edguez-Ma\u00f1as L. Frailty and sarcopenia-newly emerging and high impact complications of diabetes. J Diabetes Complicat. 2017;31(9):1465\u201373. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.05.003.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"9942_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Sun B, Huang S, Zhu C, Bian M. Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol. 2020;19(1):102. https:\/\/doi.org\/10.1186\/s12933-020-01085-6.","journal-title":"Cardiovasc Diabetol"},{"key":"9942_CR22","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ.\u00a02021;372:n71. https:\/\/www.bmj.com\/content\/372\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"9942_CR23","unstructured":"Moola S, Munn Z, Tufanaru C.\u00a0Chapter 7: Systematic Reviews of Etiology and Risk. In: Aromataris E, Munn Z, editors. Australia: Joanna Briggs Institute Reviewer's Manual. 2017;217\u201369."},{"issue":"10","key":"9942_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/19338244.2022.2042171","volume":"77","author":"V Bressan","year":"2022","unstructured":"Bressan V, Mansutti I, Longhini J, Moreale R, Caruzzo D, Libriani S, et al. Implications of quarantine among healthcare professionals: findings from a scoping review. Arch Environ Occup Health. 2022;77(10):846\u201362. https:\/\/doi.org\/10.1080\/19338244.2022.2042171.","journal-title":"Arch Environ Occup Health"},{"key":"9942_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12904-020-0520-8","volume":"19","author":"F Hasson","year":"2020","unstructured":"Hasson F, Nicholson E, Muldrew D, Bamidele O, Payne S, McIlfatrick S. International palliative care research priorities: A systematic review. BMC Palliat Care. 2020;19:16. https:\/\/doi.org\/10.1186\/s12904-020-0520-8.","journal-title":"BMC Palliat Care"},{"issue":"1","key":"9942_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12877-019-1137-8","volume":"19","author":"FY Fung","year":"2019","unstructured":"Fung FY, Koh YL, Malhotra R, Ostbye T, Lee PY, ShariffGhazali S, et al. Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatr. 2019;19(1):122. https:\/\/doi.org\/10.1186\/s12877-019-1137-8.","journal-title":"BMC Geriatr"},{"key":"9942_CR27","doi-asserted-by":"publisher","first-page":"6973469","DOI":"10.1155\/2020\/6973469","volume":"2020","author":"Q He","year":"2020","unstructured":"He Q, Wang X, Yang C, Zhuang X, Yue Y, Jing H, et al. Metabolic and nutritional characteristics in middle-aged and elderly sarcopenia patients with type 2 diabetes. J Diabetes Res. 2020;2020:6973469. https:\/\/doi.org\/10.1155\/2020\/6973469.","journal-title":"J Diabetes Res"},{"issue":"3","key":"9942_CR28","doi-asserted-by":"publisher","first-page":"e1238","DOI":"10.1210\/clinem\/dgad605","volume":"109","author":"C Herder","year":"2024","unstructured":"Herder C, Maalmi H, Saatmann N, Zaharia OP, Strassburger K, Burkart V, et al. Correlates of skeletal muscle mass and differences between novel subtypes in recent-onset diabetes. J Clin Endocrinol Metab. 2024;109(3):e1238\u201348. https:\/\/doi.org\/10.1210\/clinem\/dgad605.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9942_CR29","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/jdi.13882","volume":"13","author":"Y Hiromine","year":"2022","unstructured":"Hiromine Y, Noso S, Rakugi H, Sugimoto K, Takata Y, Katsuya T, et al. Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES-DM study. J Diabetes Investig. 2022;13(11):1881\u20138. https:\/\/doi.org\/10.1111\/jdi.13882.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"9942_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40200-020-00505-4","volume":"19","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Miyatake N, Kitayama N, Murao S, Tanaka S. An exploratory study of relationship between lower-limb muscle mass and diabetic polyneuropathy in patients with type 2 diabetes. J Diabetes Metab Disord. 2020;19(1):281\u20137. https:\/\/doi.org\/10.1007\/s40200-020-00505-4.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"9942_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4093\/dmj.2018.0036","volume":"43","author":"JA Kim","year":"2019","unstructured":"Kim JA, Hwang SY, Chung HS, Kim NH, Seo JA, Kim SG, et al. Proportion and characteristics of the subjects with low muscle mass and abdominal obesity among the newly diagnosed and drug-na\u00efve type 2 diabetes mellitus patients. Diabetes Metab J. 2019;43(1):105\u201313. https:\/\/doi.org\/10.4093\/dmj.2018.0036.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"9942_CR32","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1210\/clinem\/dgad481","volume":"109","author":"CM Mooshage","year":"2024","unstructured":"Mooshage CM, Tsilingiris D, Schimpfle L, Kender Z, Aziz-Safaie T, Hohmann A, et al. Insulin resistance is associated with reduced capillary permeability of thigh muscles in patients with type 2 diabetes. J Clin Endocrinol Metab. 2024;109(1):e137\u201344. https:\/\/doi.org\/10.1210\/clinem\/dgad481.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9942_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/jcm8030319","volume":"8","author":"N Ogama","year":"2019","unstructured":"Ogama N, Sakurai T, Kawashima S, Tanikawa T, Tokuda H, Satake S, et al. Association of glucose fluctuations with sarcopenia in older adults with type 2 diabetes mellitus. J Clin Med. 2019;8(3):319. https:\/\/doi.org\/10.3390\/jcm8030319.","journal-title":"J Clin Med"},{"issue":"26","key":"9942_CR34","doi-asserted-by":"publisher","first-page":"e26529","DOI":"10.1097\/MD.0000000000026529","volume":"100","author":"A Oguz","year":"2021","unstructured":"Oguz A, Sahin M, Tuzun D, Kurutas EB, Ulgen C, Bozkus O, et al. Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study. Medicine. 2021;100(26):e26529. https:\/\/doi.org\/10.1097\/MD.0000000000026529.","journal-title":"Medicine"},{"issue":"2","key":"9942_CR35","doi-asserted-by":"publisher","first-page":"e3231","DOI":"10.1002\/dmrr.3231","volume":"36","author":"G Orlando","year":"2020","unstructured":"Orlando G, Sacchetti M, D\u2019Errico V, Haxhi J, Rapisarda G, Pugliese G, et al. Muscle fatigability in patients with type 2 diabetes: relation with long-term complications. Diabetes Metab Res Rev. 2020;36(2):e3231. https:\/\/doi.org\/10.1002\/dmrr.3231.","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"9942_CR36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/1753-0407.13216","volume":"13","author":"S Park","year":"2021","unstructured":"Park S, Kim SH, Shin JY. Combined association of skeletal muscle mass and grip strength with cardiovascular diseases in patients with type 2 diabetes. J Diabetes. 2021;13(12):1015\u201324. https:\/\/doi.org\/10.1111\/1753-0407.13216.","journal-title":"J Diabetes"},{"key":"9942_CR37","doi-asserted-by":"publisher","first-page":"111832","DOI":"10.1016\/j.exger.2022.111832","volume":"164","author":"C Sencan","year":"2022","unstructured":"Sencan C, Dost FS, Bulut EA, Isik AT. DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients. Exp Gerontol. 2022;164:111832. https:\/\/doi.org\/10.1016\/j.exger.2022.111832.","journal-title":"Exp Gerontol"},{"key":"9942_CR38","doi-asserted-by":"publisher","first-page":"913207","DOI":"10.3389\/fendo.2022.913207","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, Liu W, Zhang L, Xiao F, Huang P, Yan B, et al. Sex-specific associations between low muscle mass and glucose fluctuations in patients with type 2 diabetes mellitus. Front Endocrinol. 2022;13:913207. https:\/\/doi.org\/10.3389\/fendo.2022.913207.","journal-title":"Front Endocrinol"},{"issue":"4","key":"9942_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jamda.2020.11.003","volume":"22","author":"K Sugimoto","year":"2021","unstructured":"Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study. J Am Med Dir Assoc. 2021;22(4):834\u20138. https:\/\/doi.org\/10.1016\/j.jamda.2020.11.003.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"9942_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-022-01468-x","volume":"21","author":"T Terada","year":"2022","unstructured":"Terada T, Reed JL, Vidal-Almela S, Mistura M, Kamiya K, Way KL. Sex-specific associations of fat mass and muscle mass with cardiovascular disease risk factors in adults with type 2 diabetes living with overweight and obesity: secondary analysis of the Look AHEAD trial. Cardiovasc Diabetol. 2022;21(1):40. https:\/\/doi.org\/10.1186\/s12933-022-01468-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"9942_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/1753-0407.13090","volume":"13","author":"T Yano","year":"2021","unstructured":"Yano T, Katano S, Kouzu H, Nagaoka R, Inoue T, Takamura Y, et al. Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus. J Diabetes. 2021;13(1):7\u201318. https:\/\/doi.org\/10.1111\/1753-0407.13090.","journal-title":"J Diabetes"},{"issue":"2","key":"9942_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4093\/dmj.2016.40.2.140","volume":"40","author":"JW Yoon","year":"2016","unstructured":"Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40(2):140\u20136. https:\/\/doi.org\/10.4093\/dmj.2016.40.2.140.","journal-title":"Diabetes Metab J"},{"key":"9942_CR43","unstructured":"World Health Organization. Body mass index - BMI. 2024; [https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index]"},{"issue":"10467","key":"9942_CR44","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"B Zhou","year":"2024","unstructured":"Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(24)02317-1.","journal-title":"Lancet"},{"issue":"1","key":"9942_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RC Ma","year":"2013","unstructured":"Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281(1):64\u201391. https:\/\/doi.org\/10.1111\/nyas.12098.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9942_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.14530","volume":"1495","author":"UP Gujral","year":"2021","unstructured":"Gujral UP, Kanaya AM. Epidemiology of diabetes among South Asians in the United States: lessons from the MASALA study. Ann N Y Acad Sci. 2021;1495(1):24\u201339. https:\/\/doi.org\/10.1111\/nyas.14530.","journal-title":"Ann N Y Acad Sci"},{"key":"9942_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nut.2018.04.011","volume":"57","author":"KW Lee","year":"2019","unstructured":"Lee KW, Lyu J, Park JK, Jo C, Kim SS. Dietary carbohydrate quality and quantity in relation to the incidence of type 2 diabetes: A prospective cohort study of middle-aged and older Korean adults. Nutrition. 2019;57:245\u201351. https:\/\/doi.org\/10.1016\/j.nut.2018.04.011.","journal-title":"Nutrition"},{"issue":"3","key":"9942_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","volume":"18","author":"D Purnamasari","year":"2022","unstructured":"Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW. Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev Diabet Stud. 2022;18(3):157\u201365. https:\/\/doi.org\/10.1900\/RDS.2022.18.157.","journal-title":"Rev Diabet Stud"},{"key":"9942_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fphys.2020.00087","volume":"11","author":"EE Howard","year":"2020","unstructured":"Howard EE, Pasiakos SM, Blesso CN, Fussell MA, Rodriguez NR. Divergent roles of inflammation in skeletal muscle recovery from injury. Front Physiol. 2020;11:87. https:\/\/doi.org\/10.3389\/fphys.2020.00087.","journal-title":"Front Physiol"},{"issue":"9","key":"9942_CR50","doi-asserted-by":"publisher","first-page":"e16042","DOI":"10.14814\/phy2.16042","volume":"12","author":"K Dondero","year":"2024","unstructured":"Dondero K, Friedman B, Rekant J, Landers-Ramos R, Addison O. The effects of myosteatosis on skeletal muscle function in older adults. Physiol Rep. 2024;12(9):e16042. https:\/\/doi.org\/10.14814\/phy2.16042.","journal-title":"Physiol Rep."},{"issue":"2","key":"9942_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.taap.2006.01.003","volume":"212","author":"AP Rolo","year":"2006","unstructured":"Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212(2):167\u201378. https:\/\/doi.org\/10.1016\/j.taap.2006.01.003.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"9942_CR52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.12365","volume":"6","author":"H Umegaki","year":"2015","unstructured":"Umegaki H. Sarcopenia and diabetes: hyperglycemia is a risk factor for age-associated muscle mass and functional reduction. J Diabetes Investig. 2015;6(6):623\u20134. https:\/\/doi.org\/10.1111\/jdi.12365.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"9942_CR53","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jamda.2021.11.025","volume":"23","author":"L Xie","year":"2022","unstructured":"Xie L, Jiang J, Fu H, Zhang W, Yang L, Yang M. Malnutrition in relation to muscle mass, muscle quality, and muscle strength in hospitalized older adults. J Am Med Dir Assoc. 2022;23(5):722\u20138. https:\/\/doi.org\/10.1016\/j.jamda.2021.11.025.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"9942_CR54","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/bjsports-2023-107849","volume":"58","author":"JJ Lang","year":"2024","unstructured":"Lang JJ, Prince SA, Merucci K, Cadenas-Sanchez C, Chaput JP, Fraser BJ, et al. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies. Br J Sports Med. 2024;58(10):556\u201366. https:\/\/doi.org\/10.1136\/bjsports-2023-107849.","journal-title":"Br J Sports Med."},{"issue":"3","key":"9942_CR55","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms24032973","volume":"24","author":"L Jun","year":"2023","unstructured":"Jun L, Robinson M, Geetha T, Broderick TL, Babu JR. Prevalence and mechanisms of skeletal muscle atrophy in metabolic conditions. Int J Mol Sci. 2023;24(3):2973. https:\/\/doi.org\/10.3390\/ijms24032973.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9942_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12902-023-01476-2","volume":"23","author":"F Ma","year":"2023","unstructured":"Ma F, Zhang Q, Shi J, Li S, Wu L, Zhang H. Risk factors for cognitive dysfunction and glycemic management in older adults with type 2 diabetes mellitus: a retrospective study. BMC Endocr Disord. 2023;23(1):220. https:\/\/doi.org\/10.1186\/s12902-023-01476-2.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"9942_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/2047487314550804","volume":"23","author":"J Auer","year":"2016","unstructured":"Auer J, Sinzinger H, Franklin B, Berent R. Muscle-and skeletal-related side-effects of statins: tip of the iceberg? Eur J Prev Cardiol. 2016;23(1):88\u2013110. https:\/\/doi.org\/10.1177\/2047487314550804.","journal-title":"Eur J Prev Cardiol"},{"key":"9942_CR58","doi-asserted-by":"publisher","first-page":"104201","DOI":"10.1016\/j.phrs.2019.03.010","volume":"154","author":"J Bouitbir","year":"2020","unstructured":"Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Kr\u00e4henb\u00fchl S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res. 2020;154:104201. https:\/\/doi.org\/10.1016\/j.phrs.2019.03.010.","journal-title":"Pharmacol Res"},{"issue":"6","key":"9942_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373\u2013418. https:\/\/doi.org\/10.2165\/0129784-200808060-00004.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"9942_CR60","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.clnu.2019.01.028","volume":"38","author":"E Poggiogalle","year":"2019","unstructured":"Poggiogalle E, Lubrano C, Gnessi L, Mariani S, Di Martino M, Catalano C, et al. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity. Clin Nutr. 2019;38(5):2430\u20135. https:\/\/doi.org\/10.1016\/j.clnu.2019.01.028.","journal-title":"Clin Nutr"},{"issue":"5","key":"9942_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","volume":"18","author":"M Zamboni","year":"2008","unstructured":"Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388\u201395. https:\/\/doi.org\/10.1016\/j.numecd.2007.10.002.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09942-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09942-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09942-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:20:09Z","timestamp":1760674809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09942-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9942"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09942-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"3 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}